Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
Lancet Rheumatol
.
2021 Aug;3(8):e542-e545.
doi: 10.1016/S2665-9913(21)00181-8.
Epub 2021 Jun 18.
Authors
Laura Boekel
1
,
Laura Y Kummer
2
,
Koos P J van Dam
2
,
Femke Hooijberg
1
,
Zoé van Kempen
3
,
Erik H Vogelzang
4
,
Luuk Wieske
2
,
Filip Eftimov
2
,
Ronald van Vollenhoven
5
,
Taco W Kuijpers
6
,
S Marieke van Ham
7
,
Sander W Tas
5
,
Joep Killestein
3
,
Maarten Boers
1
,
Mike T Nurmohamed
1
5
,
Theo Rispens
7
,
Gertjan Wolbink
1
7
Affiliations
1
Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Amsterdam, Netherlands.
2
Department of Neurology and Neurophysiology, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
3
Department of Neurology, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
4
Department of Medical Microbiology and Infection Control, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
5
Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, 1056 AB Amsterdam, Netherlands.
6
Department of Pediatric Immunology, Rheumatology and Infectious Disease, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
7
Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, Amsterdam, Netherlands.
PMID:
34179831
PMCID:
PMC8213359
DOI:
10.1016/S2665-9913(21)00181-8
No abstract available